| Dr Peyton Harvey, PHARMD | |
|
103 W Arch Ave, Searcy, AR 72143-7701 | |
| (501) 268-2536 | |
| (501) 278-5777 |
| Full Name | Dr Peyton Harvey |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 103 W Arch Ave, Searcy, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942557293 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD10733 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peyton Harvey, PHARMD 103 W Arch Ave, Searcy, AR 72143-7701 Ph: () - | Dr Peyton Harvey, PHARMD 103 W Arch Ave, Searcy, AR 72143-7701 Ph: (501) 268-2536 |
News Archive
Today, AARP released a new survey that says more than half of working Americans over age 50 (55%) don't think they'll have enough money for health care as they reach the age they expect to retire. While Medicare only covers about half of health costs, four in ten (38%) say they haven't saved anything at all for such expenses even though multiple studies show that these costs often reach more than $200,000 for a retired couple.
Soccer players who head the ball more often may be more likely to have balance problems than players who do not head the ball as often, according to a preliminary study released today that will be presented at the American Academy of Neurology's Sports Concussion Conference in Indianapolis July 20 to 22, 2018.
Preliminary results from a multicountry clinical trial, sponsored by the National Institute for Allergy and Infectious Diseases (NIAID), show that HIV-positive people who take combination antiretroviral therapy (ART) can reduce the risk of transmitting the virus to their HIV-negative partners by 96 percent, U.S. researchers announced on Thursday " in what is being hailed as a breakthrough in HIV prevention," the Los Angeles Times reports.
Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ:IPXL), today announced that it has initiated a multinational Phase III trial of its late-stage drug candidate IPX066 in advanced Parkinson's disease (PD) patients.
The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet.
› Verified 2 days ago
Dr. Brenda Bryant, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3509 E Race Ave, Wal-mart Pharmacy, Searcy, AR 72143 Phone: 501-268-4949 | |
Dr. Dibrell Wade Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1540 E Race Ave, Searcy, AR 72143 Phone: 501-268-5315 Fax: 501-279-7782 | |
Dr. James Matthew Curtis, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 W Beebe Capps Expy, Searcy, AR 72143 Phone: 501-268-4171 | |
Rebecca Ingle, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2525 W Beebe Capps Expy, Searcy, AR 72143 Phone: 501-268-4171 Fax: 501-268-4197 | |
Dr. Lara M Parkhurst, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 S Main St Ste 700, Searcy, AR 72143 Phone: 501-203-2659 Fax: 501-235-3805 | |
Shelly Ann White, PD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1540 E Race Ave, Searcy, AR 72143 Phone: 501-268-5315 | |
Dr. Samuel Hutchens, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1540 E Race Ave, Searcy, AR 72143 Phone: 501-268-5315 |